We stand with people living with cystic fibrosis, their families, care teams, and researchers. This independent lab contributes donated time, research notes, and software experiments, not clinical care or medical advice. Support the wider work through the Cystic Fibrosis Foundation.

Donate to the Cystic Fibrosis Foundation (opens another site)

AI in cystic fibrosis care

Using AI safely in CF care

Research, not medical advice

For people with cystic fibrosis (CF), their families and their care teams: what can go wrong when you ask an AI chatbot about health, what the evidence says, and what helps.

If you read only this

  1. If something is new, severe, getting worse or worries you, especially in a baby or child, do not ask a chatbot first. Call your CF team's urgent line, or your local emergency number, now.
  2. A chatbot can sound sure and still be wrong, even about the sources it names. Why
  3. Treat what a chatbot says as a draft until you have checked it on the official page or with your care team. What to check
  4. Leave out your name and anything else that could identify you or someone else. Why
  5. Tell your care team which AI tools you use. Why this helps

Our advice: do not start, stop, skip or change a medicine or treatment because of what a chatbot said; talk to your care team first. Ask your care team now what counts as urgent for you and where the after-hours number is, and keep it saved on your phone.

Each sourced sentence on this page is checked by a script against an exact quote from what we read of its source. The advice is the lab's own and is marked as ours. The sources, and how much of each we read, are listed at the end.

Why people turn to AI

A chatbot answers at any hour, in plain words, without a wait. That is our own observation, not a study finding. We have not read a study of how many people with CF use AI chatbots, or why, and we will not guess.

Sources Evidence: limited

In plain words. Health care providers around the world are exploring AI to give medical advice to the public. In a survey the American Psychological Association (APA) cites, about a third of teens said they would rather talk with an AI companion than with a person about something serious or important.

Health care providers around the world are exploring the use of AI language models to give medical advice to the public. A study notes that online patient education materials often exceed the recommended sixth-grade reading level.

The American Psychological Association (APA) says early research suggests that some chatbots and apps built for mental health may offer support in some situations. In a finding the APA cites, 33% of teens said they would rather talk about something serious or important with an AI companion than with a person.

Limited: four sentences from three sources, none about CF. Originals: Bean and others (preprint); Will and others (JMIR); APA health advisory (PDF).

What can go wrong

Each topic starts with what to do; that advice is ours. Open Sources under it for the sourced sentences, how strong they are, and the originals. Strong means a source answers the question directly and we read it in full; Limited, that it is small, indirect or partly read; Not found, that we found nothing to rely on. No topic is rated Strong yet. Several topics cite the American Psychological Association (APA), whose advisory on AI chatbots in mental health care we read in part.

Tell your care team

A chatbot does not know you. The people who do are still the ones to talk to. The APA strongly recommends that people tell their health providers which AI tools or wellness apps they use. Use AI to prepare questions for your visit, not to make decisions.

If your child or teen uses a chatbot (our advice). Using a chatbot is not something to hide. Ask what they use it for, without blame, and tell your care team.

For care teams. The APA also says clinicians should ask patients about their use of AI chatbots and wellness apps. Our advice: ask without judgment, so people feel safe to tell you. Keep time for the conversation: a tool can draft; a person explains and listens. Do not put patient information into a consumer chatbot; use only tools your organization has approved, and ask your privacy or compliance office if unsure.

Questions to ask about any AI tool

The lab's own questions, for anyone choosing or running a tool, over its whole life.

  1. Who built it, and with whom? Were people with CF and caregivers involved?
  2. What data did it learn from, and does that data include people like the ones it will serve?
  3. How is it offered, and what do people agree to? Can they say no and still get care?
  4. How are its mistakes watched, reported and fixed after it goes live?
  5. Does it support human decisions, or quietly make them? Do staff keep using their own skills?
  6. How do you stop using it, and what happens to the data then?

The US National Institute of Standards and Technology (NIST) has an AI Risk Management Framework, for voluntary use, to help build trustworthiness into how AI is designed, developed, used and evaluated. NIST released a Generative AI Profile for the framework on July 26, 2024. Our questions are not taken from it, and we read only its landing page (AI Risk Management Framework).

What the lab does about this

The lab makes free tools for these concerns, in cf-skills on GitHub. Each has a version you paste into a chat, with no install, and a guide says where to paste it. Start with cf-ai-safe-use: the other four build on it. They help; they do not make a chatbot safe.

  • Made-up facts and sources → cf-answer-check splits an AI answer into claims. Each stays “Not checked” until you paste the exact words from a source you opened.
  • Answers that agree with you → cf-ai-safe-use tells the assistant to be kind in tone but honest in content, and not to simply agree.
  • Trusting the machine too much → cf-answer-check starts with “Do not act on this until your care team confirms it” for any claim that would stop or delay a treatment.
  • Privacy → cf-ai-safe-use asks you to leave out names and dates, and tells the assistant not to repeat them.
  • Emotional support → cf-ai-safe-use meets distress with warmth first, then points to people. For an urgent symptom it says to call your care team or local emergency number.
  • Language and translation → nothing yet. A language-access skill is on our list and needs input from a clinician or interpreter.
  • Your own rewrite has no checker → cf-plain-language-rewrite keeps every number, name and warning, and lists each for you to check. Its script flags any that were added, dropped or changed.
  • Who checks the tool? → cf-ai-tool-review is a worksheet for a group. An unknown stays “unknown”, and people decide.
  • Facts that change → cf-ai-safe-use tells the assistant not to give doses or numbers from memory, except 911 in the US.
  • Getting ready for a visit → cf-visit-prep turns worries into questions for your care team. It does not answer the medical question, and ends by telling you not to wait if something is new or worse.
Clinical Safety Boundary & Evidence Tier Verification Gate
Clinical Safety Boundary & Evidence Tier Verification Gate Schematic of the lab verification gate: Primary Source Catalog, Deterministic Claim Checkers, Frontier Review Council, and Licensed CF Care Team Boundary. Research, not medical advice. Schematic, not a structure. T1 Primary Catalog Exact Quotes catalog.yaml T2 Claim Checkers check_claims.py SHA-256 Lock T2+ Frontier Council Claude · Gemini Cross-Model QA T3 Care Team Gate Licensed Clinician Human Authority [Tier T1-T3 Verification Gate · catalog.yaml + check_claims.py · Schematic, not a structure · Research, not medical advice]
Deterministic four-tier evidence verification pipeline from primary catalog to clinical care team boundary. Schematic, not a structure. Research, not medical advice.

Where this page stands

The lab grades what it says from T0 (a summary or memory, not checked) through T1 (a quote from the source, with its name and date) and T2 (T1, plus a script check and a check by a different AI model) to T3 (T2, plus a person’s review). T2 is the lab’s bar for public claims; T3, for anything that could affect a person’s care. Each sourced sentence here has an exact quote from its source, checked by a script. Two other AI models read each sentence against its source text and flagged nothing; our own reading found two sentences to narrow, and we did. A model’s clean pass says little, and several sources were read only as a summary or extracts (the list at the end says which), so the page is not yet T2 for those.

Our rules, and what the tools cannot do
  • The evidence tool reads only sources its list allows, calls no AI model and states each record’s limits.
  • A script checks quotes are word for word; another model or a person reads each against its sentence.
  • No patient data goes in the lab’s files, AI prompts or logs.
  • A model may propose work; a person decides.
  • On three hosted models, replies passed far more often with the pasted instructions, but some still wrote a phone number or named a service from memory. Other assistants are not tested yet (grid).
  • The checking scripts read English only and can miss a name.

What this page does not do

  • It is not medical advice. It gives no dosing, no eligibility and no treatment advice.
  • It is not about any product. It does not rate any company or tool. Where a source is a company's page, it is there as an example of what such pages say.
  • It is not complete. It rests on the few sources below, read on 2026-10-08, and AI tools and their policies change.
  • The lab is independent. It is not affiliated with the Cystic Fibrosis Foundation or any conference, and no one has endorsed this page.

To send a correction or a question, use the Contact page.

Where this comes from

Twelve sources, read on 2026-10-08 or audited October 17, 2026. Each says how much of it we read: “read in full from open access” means the complete paper was retrieved and verified word for word; “abstract read” means the summary at the top of a paper. The claims file behind this page, with the exact quote for each sentence, is docs/ai-in-care-claims.json in the site's repository.

The twelve sources, and how much of each we read
  • Clinical knowledge in LLMs does not translate to human interactionsBean and others · arXiv · 2025 · preprint · read in full from open access · arXiv 2504.18919
  • Evaluating Verifiability in Generative Search EnginesLiu and others · arXiv · 2023 · preprint · read in full from open access · arXiv 2304.09848
  • Fabrication and errors in the bibliographic citations generated by ChatGPTWalters and Wilder · Scientific Reports · 2023 · peer-reviewed · read in full from open access · PMC10484980
  • Towards Understanding Sycophancy in Language ModelsSharma and others · arXiv · 2023, version 4 in 2025 · preprint · read in full from open access · arXiv 2310.13548
  • Automation bias: a systematic review of frequency, effect mediators, and mitigatorsGoddard and others · Journal of the American Medical Informatics Association · 2012 · peer-reviewed review · read in full from open access · PMC3240751
  • APA Health Advisory on the Use of Generative AI Chatbots and Wellness Applications for Mental HealthAmerican Psychological Association · November 2025 · professional body · pages 1 to 7 read in full, the rest searched by keyword · PDF on apa.org
  • Complying with FTC's Health Breach Notification RuleUS Federal Trade Commission · July 2024 · regulator guidance · page read, as extracts · ftc.gov
  • Is my data used for model training?Anthropic, Claude privacy center · updated March 16, 2026 · company page, one example only · page read, as extracts · privacy.claude.com
  • Clinical Decision Support SoftwareUS Food and Drug Administration · January 2026 · regulator guidance · landing page read, guidance document not read · fda.gov
  • Performance of ChatGPT and Google Translate for Pediatric Discharge Instruction TranslationPediatrics · 2024 · peer-reviewed · a summary of the abstract read, not the abstract word for word · PMID 38860299
  • Enhancing the Readability of Online Patient Education Materials Using Large Language Models: Cross-Sectional StudyWill and others · Journal of Medical Internet Research · 2025 · peer-reviewed · abstract read, background and conclusions word for word · PMC12177420
  • AI Risk Management FrameworkUS National Institute of Standards and Technology · 2023 · government standards body · landing page read, framework documents not read · nist.gov

What we could not find or read

  • A study of chatbots giving wrong phone numbers or help services, out-of-date medicine or label information, or wrong insurance or eligibility advice.
  • A study of AI-written misinformation in CF communities, or a randomized trial showing that a mental health chatbot helps.
  • A statement on AI chatbots from the Cystic Fibrosis Foundation, the European Cystic Fibrosis Society or a CF journal, in one search. The Foundation's site refused our automated requests.
  • The US health department's pages on health apps and HIPAA, which refused our requests; any state law text; the World Health Organization's guidance on large AI models.
Seen but not used
  • A 2026 preprint on the quality of AI-generated CF microbiology information: we saw only a summary, and the publisher's page refused our requests (DOI).
  • A letter in JMIR AI, “Who Reviews the Rewrite?”: we could read only part of it (PMC13528825).
  • A study of machine translation of discharge instructions into Spanish, Chinese and Russian: summary only (PMID 40633961).
  • A preprint on chatbots as mental health providers (arXiv 2504.18412): we saw only a paraphrase. A US state law on AI therapy: we saw only a search snippet.